Clinical Trial Update: Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating preoperative pembrolizumab plus radiation therapy in breast cancer, including triple-negative and HR-positive/HER2-nega…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone Receptor-positive Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Laura M. Spring, MD | Conditions: Triple Negative Breast Cancer, Hormone Receptor Positive (HR+), HER2-negative Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING